Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses

Targeting Triple Negative Breast Cancer With Oncolytic Adenoviruses

Breast cancer (BC) is the most common cancer globally, accounting for 685,000 deaths in 2020. Triple-negative breast cancers (TNBC) lack oestrogen (ER) and progesterone (PR) hormone receptor expression and HER2 overexpression. TNBC represent 10–15% of all BC with high incidence in women under 50-yea...

Full description

Bibliographic Details
Main Authors:	Gabriela Green-Tripp, Callum Nattress, Gunnel Halldén
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Molecular Biosciences
Subjects:	tumour-selective novel therapies lysis immune activation metastatic breast cancer OAd
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2022.901392/full

Similar Items

HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models
by: María Del Carmen Rodríguez Rodríguez, et al.
Published: (2022-05-01)

Effect of Transgene Location, Transcriptional Control Elements and Transgene Features in Armed Oncolytic Adenoviruses
by: Martí Farrera-Sal, et al.
Published: (2020-04-01)

Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models
by: Yang Kee Stella Man, et al.
Published: (2022-08-01)

Where do conventional OADs stand
by: Rakesh Kumar Sahay, et al.
Published: (2012-01-01)

Hubungan antara Tingkat Pengetahuan dengan Kepatuhan Pasien dalam Menjalani Terapi Obat Antidiabetes Oral pada Diabetes Mellitus Tipe 2 di Rumah Sakit Universitas Airlangga Tahun 2015
by: Firda Iragama, et al.
Published: (2017-07-01)

Designer Oncolytic Adenovirus: Coming of Age
by: Alexander T. Baker, et al.
Published: (2018-06-01)

Expression of SOX10 in Triple-negative Breast Cancer.
by: Siyab Ahmad , Nadeem Zafar , Muhammad Owais Qurni , Muhammad Atif Khalil , Shabir Ahmad Orakzai , Wajahat Ahmad Khan
Published: (2023-09-01)

Payload Delivery: Engineering Immune Cells to Disrupt the Tumour Microenvironment
by: Daniel Fowler, et al.
Published: (2021-11-01)

Overcoming challenges to enable targeting of metastatic breast cancer tumour microenvironment with nano-therapeutics: Current status and future perspectives
by: Karishma Niveria, et al.
Published: (2022-11-01)

Triple Negative Invasive Ductal Carcinoma of Breast with Oral Metastasis: A Case Report
by: Sabaritha Ramamoorthy, et al.
Published: (2023-05-01)

Response to cisplatin in a metastatic triple-negative breast cancer patient
by: Budhi Singh Yadav, et al.
Published: (2021-01-01)

Comparison of Lysis and Detachment Sample Preparation Methods for Cultured Triple-Negative Breast Cancer Cells Using UHPLC–HRMS-Based Metabolomics
by: Blake R. Rushing, et al.
Published: (2022-02-01)

Oncolytic adenovirus encoding apolipoprotein A1 suppresses metastasis of triple-negative breast cancer in mice
by: Jie Dong, et al.
Published: (2024-04-01)

Structure and Morphological Properties of Cadmium Oxide Nanostructure Prepared By Oblique Angle Deposition Method
by: Wafaa K. Khalef, et al.
Published: (2015-11-01)

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
by: Sara Bravaccini, et al.
Published: (2021-11-01)

Combination of Ixabepilone and Capecitabine in Metastatic Triple Negative Breast Cancer. Clinical case
by: E. V. Glazkova, et al.
Published: (2019-12-01)

Oncolytic virotherapy for metastatic breast cancer – a case report
by: Benjamin Gesundheit, et al.
Published: (2023-06-01)

Tumour lysis syndrome: A rare acute presentation of locally advanced testicular cancer – Case report and review of literature
by: Marcus Chow, et al.
Published: (2016-01-01)

Systemic Therapy for Metastatic Triple Negative Breast Cancer: Current Treatments and Future Directions
by: Laura Morrison, et al.
Published: (2023-07-01)

The role of IMP3 immunohistochemistry expression in triple-negative breast cancer as a prognostic factor
by: K Kamala, et al.
Published: (2024-01-01)

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
by: Md Abdus Subhan, et al.
Published: (2023-04-01)

Real-World Data from a Refractory Triple-Negative Breast Cancer Cohort Selected Using a Clinical Data Warehouse Approach
by: Hana Kim, et al.
Published: (2021-11-01)

New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy
by: Hanna Chowaniec, et al.
Published: (2024-03-01)

Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
by: Marshall D. Behrens, et al.
Published: (2022-12-01)

Pathological Complete Response with Platinum Containing Neoadjuvant Chemotherapy in Triple-negative Breast Cancer: An Interventional Study
by: Binila Mary Jose, et al.
Published: (2024-04-01)

Determination of the androgen receptor status of circulating tumour cells in metastatic breast cancer patients
by: Natalia Krawczyk, et al.
Published: (2019-11-01)

Unveiling the Potential of Liquid Biopsy in HER2-Positive Breast Cancer Management
by: Ana Godoy-Ortiz, et al.
Published: (2022-01-01)

Triple-Negative Breast Cancer: Basic Biology and Immuno-Oncolytic Viruses
by: Michael L. Monaco, et al.
Published: (2023-04-01)

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancerResearch in context
by: Andrew A. Davis, et al.
Published: (2022-12-01)

Exploring the relationship between cancer metabolism and oncolytic adenoviruses
by: Dyer, A
Published: (2021)

Current Therapeutic Strategies for Metastatic Triple-Negative Breast Cancer: From Pharmacists’ Perspective
by: Shuanghe Li, et al.
Published: (2022-10-01)

Targeting Thioredoxin System with an Organosulfur Compound, Diallyl Trisulfide (DATS), Attenuates Progression and Metastasis of Triple-Negative Breast Cancer (TNBC)
by: Yuping Liu, et al.
Published: (2018-11-01)

NEW STRATEGY FOR DRUG TREATMENT OF LUMINAL HER2-NEGATIVE METASTATIC BREAST CANCER
by: E. V. ARTAMONOVA
Published: (2017-06-01)

Encapsulated Rose Bengal Enhances the Photodynamic Treatment of Triple-Negative Breast Cancer Cells
by: Mir Muhammad Nasir Uddin, et al.
Published: (2024-01-01)

Targeting EGFR signalling pathway in triple negative breast cancer
by: Albukhari, A
Published: (2014)

Targeting EGFR signalling pathway in triple negative breast cancer
by: Albukhari, A
Published: (2014)

Biochemical and Anti-Triple Negative Metastatic Breast Tumor Cell Properties of Psammaplins
by: Yu-Dong Zhou, et al.
Published: (2018-11-01)

Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer
by: Lin Ang, et al.
Published: (2022-07-01)

Association of androgen receptor and tumour-infiltrating lymphocytes with bone recurrence in triple-negative breast cancer
by: Petra Ilenič, et al.
Published: (2024-02-01)

Preclinical platforms to study therapeutic efficacy of human γδT‐cells for oncology indications
by: Marta Barisa, et al.
Published: (2022-06-01)